O

Olivier Michielin

SIB Swiss Institute of Bioinformatics

ORCID: 0000-0003-4926-6355

Publishes on Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research. 491 papers and 56.6k citations.

PubIndex Score98Top 2%How it's scored

🌟#3 Current Senior Leader in Computational Drug Discovery Methods 🌟#3 Current Senior Leader in Pharmacogenetics and Drug Metabolism 🌟#4 Current Senior Leader in Analytical Chemistry and Chromatography

491Publications

56.6kTotal Citations

#3in Computational Drug Discovery Methods

First publication: 1994First senior author: 2004

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research Melanoma and MAPK Pathways Cutaneous Melanoma Detection and Management

Top publicationsby citations

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Olivier Michielin, Ulrich Keilholz, Alexander C. J. van Akkooi et al.|Annals of Oncology|2019

Cited by 621

Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma

Ximena Bonilla, Sergey I. Nikolaev, Laurent Parmentier et al.|Nature Genetics|2016

Cited by 495

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

Giuseppe Curigliano, Uwe G. Liebert, Susana Banerjee et al.|Annals of Oncology|2020

Cited by 313

ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee

Ulrich Keilholz, Olivier Michielin, Helen Gogas et al.|Annals of Oncology|2020

Cited by 232

Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma

Lisa Haas, Anna C. Obenauf, Anais Elewaut et al.|Nature Cancer|2021

Cited by 196